What is the projected market valuation of the Biopharmaceutical Excipients Market by 2035?

The projected market valuation of the Biopharmaceutical Excipients Market is expected to reach 12.4 USD Billion by 2035. Read More

What was the market valuation of the Biopharmaceutical Excipients Market in 2024?

The overall market valuation of the Biopharmaceutical Excipients Market was 7.18 USD Billion in 2024. Read More

What is the expected CAGR for the Biopharmaceutical Excipients Market during the forecast period 2025 - 2035?

The expected CAGR for the Biopharmaceutical Excipients Market during the forecast period 2025 - 2035 is 5.09%. Read More

Which application segment is projected to have the highest valuation by 2035?

The Injectable Formulations segment is projected to reach a valuation of 2.5 USD Billion by 2035. Read More

Which end-use segment is expected to dominate the market by 2035?

The Pharmaceutical Companies segment is expected to dominate the market, projected to reach 6.0 USD Billion by 2035. Read More

Who are the leading players in the Biopharmaceutical Excipients Market?

Key players in the market include BASF SE, Evonik Industries AG, Dow Inc., and Merck KGaA. Read More

What is the projected valuation for the Active Excipients segment by 2035?

The Active Excipients segment is projected to reach a valuation of 4.6 USD Billion by 2035. Read More

How does the market for Multi-functional Excipients compare to Functional Excipients by 2035?

By 2035, the Multi-functional Excipients segment is expected to reach 3.5 USD Billion, while Functional Excipients may reach 2.5 USD Billion. Read More

What is the anticipated growth trend for the Cell and Gene Therapy segment by 2035?

The Cell and Gene Therapy segment is anticipated to grow to 3.1 USD Billion by 2035. Read More

Biopharmaceutical Excipients Market

Q: What are the key types of excipients in the Biopharmaceutical Excipients Market?

Key types of excipients include Binders, Disintegrants, Lubricants, Preservatives, and Stabilizers. Read More

Biopharmaceutical Excipients Market Research Report By Application (Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy), By Type (Binders, Disintegrants, Lubricants, Preservatives, Stabilizers), By Functionality (Functional Excipients, Multi-functional Excipients, Inert Excipients, Active Excipients), By End-use (Pharmaceutical Companies, Contract Manufacturing Organizations, Research Institutes), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.09%

2024 Market Size

$ 7.18 Billion

2035 Market Size

$ 12.4 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/9128-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Billion) | |
  1. 4.1.1 Injectable Formulations | |
  2. 4.1.2 Oral Formulations | |
  3. 4.1.3 Topical Formulations | |
  4. 4.1.4 Transdermal Formulations | |
  5. 4.1.5 Cell and Gene Therapy |
2. 4.2 Healthcare, BY Type (USD Billion) | |
  1. 4.2.1 Binders | |
  2. 4.2.2 Disintegrants | |
  3. 4.2.3 Lubricants | |
  4. 4.2.4 Preservatives | |
  5. 4.2.5 Stabilizers |
3. 4.3 Healthcare, BY Functionality (USD Billion) | |
  1. 4.3.1 Functional Excipients | |
  2. 4.3.2 Multi-functional Excipients | |
  3. 4.3.3 Inert Excipients | |
  4. 4.3.4 Active Excipients |
4. 4.4 Healthcare, BY End-use (USD Billion) | |
  1. 4.4.1 Pharmaceutical Companies | |
  2. 4.4.2 Contract Manufacturing Organizations | |
  3. 4.4.3 Research Institutes |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 BASF SE (DE) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Evonik Industries AG (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Dow Inc. (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 FMC Corporation (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 JRS Pharma (DE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Ashland Global Holdings Inc. (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Merck KGaA (DE) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Sodium Hyaluronate (JP) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Croda International Plc (GB) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY TYPE |
8. 6.5 US MARKET ANALYSIS BY FUNCTIONALITY |
9. 6.6 US MARKET ANALYSIS BY END-USE |
10. 6.7 CANADA MARKET ANALYSIS BY APPLICATION |
11. 6.8 CANADA MARKET ANALYSIS BY TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY FUNCTIONALITY |
13. 6.10 CANADA MARKET ANALYSIS BY END-USE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION |
16. 6.13 GERMANY MARKET ANALYSIS BY TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY FUNCTIONALITY |
18. 6.15 GERMANY MARKET ANALYSIS BY END-USE |
19. 6.16 UK MARKET ANALYSIS BY APPLICATION |
20. 6.17 UK MARKET ANALYSIS BY TYPE |
21. 6.18 UK MARKET ANALYSIS BY FUNCTIONALITY |
22. 6.19 UK MARKET ANALYSIS BY END-USE |
23. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION |
24. 6.21 FRANCE MARKET ANALYSIS BY TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY FUNCTIONALITY |
26. 6.23 FRANCE MARKET ANALYSIS BY END-USE |
27. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION |
28. 6.25 RUSSIA MARKET ANALYSIS BY TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY FUNCTIONALITY |
30. 6.27 RUSSIA MARKET ANALYSIS BY END-USE |
31. 6.28 ITALY MARKET ANALYSIS BY APPLICATION |
32. 6.29 ITALY MARKET ANALYSIS BY TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY FUNCTIONALITY |
34. 6.31 ITALY MARKET ANALYSIS BY END-USE |
35. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION |
36. 6.33 SPAIN MARKET ANALYSIS BY TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY FUNCTIONALITY |
38. 6.35 SPAIN MARKET ANALYSIS BY END-USE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY FUNCTIONALITY |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY APPLICATION |
45. 6.42 CHINA MARKET ANALYSIS BY TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY FUNCTIONALITY |
47. 6.44 CHINA MARKET ANALYSIS BY END-USE |
48. 6.45 INDIA MARKET ANALYSIS BY APPLICATION |
49. 6.46 INDIA MARKET ANALYSIS BY TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY FUNCTIONALITY |
51. 6.48 INDIA MARKET ANALYSIS BY END-USE |
52. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION |
53. 6.50 JAPAN MARKET ANALYSIS BY TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY FUNCTIONALITY |
55. 6.52 JAPAN MARKET ANALYSIS BY END-USE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY FUNCTIONALITY |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION |
61. 6.58 MALAYSIA MARKET ANALYSIS BY TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY FUNCTIONALITY |
63. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE |
64. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION |
65. 6.62 THAILAND MARKET ANALYSIS BY TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY FUNCTIONALITY |
67. 6.64 THAILAND MARKET ANALYSIS BY END-USE |
68. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION |
69. 6.66 INDONESIA MARKET ANALYSIS BY TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY FUNCTIONALITY |
71. 6.68 INDONESIA MARKET ANALYSIS BY END-USE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION |
73. 6.70 REST OF APAC MARKET ANALYSIS BY TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY FUNCTIONALITY |
75. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION |
78. 6.75 BRAZIL MARKET ANALYSIS BY TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY FUNCTIONALITY |
80. 6.77 BRAZIL MARKET ANALYSIS BY END-USE |
81. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION |
82. 6.79 MEXICO MARKET ANALYSIS BY TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY FUNCTIONALITY |
84. 6.81 MEXICO MARKET ANALYSIS BY END-USE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION |
86. 6.83 ARGENTINA MARKET ANALYSIS BY TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY FUNCTIONALITY |
88. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTIONALITY |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY FUNCTIONALITY |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY FUNCTIONALITY |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION |
103. 6.100 REST OF MEA MARKET ANALYSIS BY TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY FUNCTIONALITY |
105. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY FUNCTIONALITY, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY FUNCTIONALITY, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY END-USE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY END-USE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY END-USE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY END-USE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY END-USE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY END-USE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY END-USE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY END-USE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY END-USE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY END-USE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY END-USE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY END-USE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY END-USE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY END-USE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY END-USE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY END-USE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY END-USE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY END-USE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY END-USE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY END-USE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY END-USE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY END-USE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY END-USE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY END-USE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY END-USE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY END-USE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY END-USE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY END-USE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY FUNCTIONALITY, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY END-USE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Biopharmaceutical Excipients Market Segmentation

Biopharmaceutical Excipients Market By Application (USD Billion, 2025-2035)

Injectable Formulations
Oral Formulations
Topical Formulations
Transdermal Formulations
Cell and Gene Therapy

Biopharmaceutical Excipients Market By Type (USD Billion, 2025-2035)

Binders
Disintegrants
Lubricants
Preservatives
Stabilizers

Biopharmaceutical Excipients Market By Functionality (USD Billion, 2025-2035)

Functional Excipients
Multi-functional Excipients
Inert Excipients
Active Excipients

Biopharmaceutical Excipients Market By End-use (USD Billion, 2025-2035)

Biopharmaceutical Excipients Market Companies
Contract Manufacturing Organizations
Research Institutes

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”